Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.

Breast cancer (Tokyo, Japan) - 1 Sept 2015

Nakamura Seigo, Takahashi Masato, Tozaki Mitsuhiro, Nakayama Takahiro, Nomizu Tadashi, Miki Yoshio, Murakami Yoshie, Aoki Daisuke, Iwase Takuji, Nishimura Seiichiro, Yamauchi Hideko, Ohsumi Shozo, Baba Shinichi, Shimizu Tadao

Abstract excerpt

BACKGROUND: We assembled needed data on the prevalence and characteristics of BRCA1/2 in Japan. MATERIALS AND METHODS: Our study of BRCA1/2 collected data at eight institutions in Japan on 320 individuals with a strong family history of breast cancer, according to the NCCN guidelines, by the end of March 2012. RESULTS: Among 260 proband cases, 46 (17.7 %) were positive for BRCA1, and 35 (13.5 %) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Breast Neoplasms, Male

Share to Mutation Rate

Share to Ovarian Neoplasms

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 24249303
DOI: 10.1007/s12282-013-0503-1

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.PMID 24249303Read ↗

Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.Semantic proximity Read ↗

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63XSemantic proximity Read ↗

The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.Semantic proximity Read ↗

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.Semantic proximity Read ↗

BRCA testing and Japanese original testing criteria for hereditary breast and ovarian cancer covered by public health insuranceSemantic proximity Read ↗

Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Efficacy of clinical guidelines in identifying all Japanese patients with hereditary breast and ovarian cancerSemantic proximity Read ↗

Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.Semantic proximity Read ↗

The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.Semantic proximity Read ↗

Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese Organization of Hereditary Breast and Ovarian Cancer registry dataSemantic proximity Read ↗

Familial breast and ovarian cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.